Clinical Trial Update: Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in CINV (Chemotherapy-induced Nausea and Vomiting) Associated With the Administration of MEC (Moderately Emetogenic Chemotherapy) [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the efficacy and safety of the Sancuso transdermal granisetron patch for preventing chemotherapy-induced nausea and vomiting in patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Sancuso patch (granisetron transdermal system)

Snippet

Sponsor: LG Life Sciences | Conditions: Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV) | Phase 4 | Status: UNKNOWN